2m 2m 2m 2m 2m 2m 2m
Lexicon Pharma (LXRX)
NASDAQ
$2.18+$0.005 (+0.23%)
Price as of Jul 13, 2026 7:22 PM EDT- $963.9MMarket Cap
- 83.90%1-Year Change
- BiotechnologyIndustry
Lexicon Pharma (LXRX)
$2.18+$0.005 (+0.23%)
LXRX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.17 | ||
Change | -$0.05 (-2.25%) | ||
Open | $2.20 | ||
High | $2.22 | ||
Low | $2.14 | ||
Previous Close | $2.22 | ||
Volume | 1,705,614 | ||
30-Day Average Volume | 4,911,792 | ||
1-Week Change | -6.47% | ||
1-Month Change | 13.02% | ||
1-Year Change | 83.90% | ||
3-Year Change | -5.65% | ||
5-Year Change | -44.07% | ||
Fundamentals | |||
Shares Outstanding | 444.2M | ||
Total Assets | $268.8M | ||
Market Cap | $963.9M | ||
Enterprise Value | $975.5M | ||
Period: QTR TTM FY | |||
Revenue | $21.1M | ||
Net Income | -$1.0M | ||
Free Cash Flow | -$14.7M | ||
EBIT | -$1.0M | ||
EBITDA | -$933,000.00 | ||
Net Working Capital | $176.1M | ||
EPS | N/A | ||
Enterprise Value/EBITDA | -1,046 | ||
Enterprise Value/Revenue | 46 | ||
P/B | 5 | ||
P/E | N/A | ||
PEG | N/A | ||
Price/Free Cash Flow | -65 | ||
Price/Operating Cash Flow | -65 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 7 | ||
Last Split Date | 05/21/2015 | ||
Earnings & Revenue